Dickens, N.J. et al. (2010) Homozygous deletion mapping in myeloma samples identifies genes and an expression signature relevant to pathogenesis and outcome. Clinical Cancer Research, 16(6), pp. 1856-1864. (doi: 10.1158/1078-0432.CCR-09-2831)
Full text not currently available from Enlighten.
Abstract
We developed a simple 6-gene expression signature from the 97-gene signature that can be used to identify poor-prognosis myeloma in the clinical environment. This signature could form the basis of future trials aimed at improving the outcome of poor-prognosis myeloma.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Dickens, Dr Nicholas |
Authors: | Dickens, N.J., Walker, B.A., Leone, P.E., Johnson, D.C., Brito, J.L., Zeisig, A., Jenner, M.W., Boyd, K.D., Gonzalez, D., Gregory, W.M., Ross, F.M., Davies, F.E., and Morgan, G.J. |
Subjects: | R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) |
College/School: | College of Medical Veterinary and Life Sciences > School of Infection & Immunity |
Journal Name: | Clinical Cancer Research |
Publisher: | American Association for Cancer Research |
ISSN: | 1078-0432 |
ISSN (Online): | 1557-3265 |
University Staff: Request a correction | Enlighten Editors: Update this record